---
figid: PMC7542154__41392_2020_324_Fig3_HTML
figtitle: Immunoregulation of PD-L1/PD-1 in GBC
organisms:
- Adenoviridae
- Avian erythroblastosis virus
- Homo sapiens
- Mus musculus
- Gallus gallus
- Helicobacter pylori
- Olea europaea
pmcid: PMC7542154
filename: 41392_2020_324_Fig3_HTML.jpg
figlink: pmc/articles/PMC7542154/figure/Fig3/
number: F3
caption: Immunoregulation of PD-L1/PD-1 in GBC. a Activated ERBB2/ERBB3 mutations
  upregulate PD-L1 expression through activation of the PI3K/AKT signaling and RAS/RAF/MEK/ERK
  pathway to induce immune evasion of GBC cells. b Yellow boxes highlight that drug
  targeted ERBB2, PD-1, or PD-L1 could dampen immune evasion of GBC cells
papertitle: Overview of current targeted therapy in gallbladder cancer.
reftext: Xiaoling Song, et al. Signal Transduct Target Ther. 2020;5:230.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9612258
figid_alias: PMC7542154__F3
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Gallus gallus
redirect_from: /figures/PMC7542154__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7542154__41392_2020_324_Fig3_HTML.html
  '@type': Dataset
  description: Immunoregulation of PD-L1/PD-1 in GBC. a Activated ERBB2/ERBB3 mutations
    upregulate PD-L1 expression through activation of the PI3K/AKT signaling and RAS/RAF/MEK/ERK
    pathway to induce immune evasion of GBC cells. b Yellow boxes highlight that drug
    targeted ERBB2, PD-1, or PD-L1 could dampen immune evasion of GBC cells
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Erbb2
  - Egfr
  - Erbb3
  - Pik3r1
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Mdk
  - Mtor
  - Ephb2
  - Mapk1
  - Pdcd1
  - Cd274
  - ERBB2
  - EGFR
  - ERBB3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - EPHB2
  - MAPK1
  - MAPK3
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - CD274
  - afatinib
  - neratinib
  - dacomitinib
  - lapatinib
---
